Improve Lives

COVID-19 Clinical Trials: Meridian is still seeking participants for Phase 2 and 3 COVID-19 vaccine studies in Georgia (Savannah), Louisiana (Baton Rouge), Maryland (Rockville), Nebraska (Grand Island, Norfolk, and Omaha), New York (Binghamton and Endwell), and Sioux City (Iowa). Read more >

Help improve lives.
Enjoy the experience.

Help move science forward

Clinical studies offer a way for almost anyone — regardless of their background — to help improve human health and wellbeing.

Get paid for participating

Most Meridian studies offer payment for time and travel. We'll let you know what to expect during your first phone call with Meridian.

Get early access to new medicines

Clinical studies offer more care options for patients suffering from common, unique, and rare health conditions.

Patients enrolled
Studies conducted
Sites across the U.S.

Clients and partners

Meridian provides Phase I-IV research services for Sponsors and CROs developing drugs, medical devices, and diagnostics across numerous therapeutic areas.

Amgen, Abbvie, Abbott, AstraZeneca, Bayer, Bristol-Meyers Squibb, Dermira, Genentech, GlaxcoSmithKline, Johnson and Johnson, Medicago, Merck, Moderna, Novartis, NovoNordisk, Pfizer, Regeneron. Sanofi Pasteur. Seqirus, Takeda